LEO, Eliana Grazia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.362
AS - Asia 9.316
EU - Europa 8.384
SA - Sud America 1.331
Continente sconosciuto - Info sul continente non disponibili 321
AF - Africa 204
OC - Oceania 53
Totale 37.971
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.971
SG - Singapore 2.695
GB - Regno Unito 2.587
CN - Cina 2.549
IT - Italia 1.965
HK - Hong Kong 1.067
VN - Vietnam 1.066
SE - Svezia 1.039
BR - Brasile 1.031
DE - Germania 637
BD - Bangladesh 409
FR - Francia 372
UA - Ucraina 362
FI - Finlandia 360
RU - Federazione Russa 351
KR - Corea 308
TR - Turchia 278
IN - India 265
CA - Canada 195
BG - Bulgaria 151
AR - Argentina 114
NL - Olanda 107
ID - Indonesia 101
MX - Messico 92
JP - Giappone 87
BE - Belgio 77
IQ - Iraq 70
ZA - Sudafrica 62
PL - Polonia 56
ES - Italia 52
PK - Pakistan 47
AE - Emirati Arabi Uniti 46
IR - Iran 46
CO - Colombia 42
EC - Ecuador 42
IE - Irlanda 41
PH - Filippine 39
AU - Australia 38
CL - Cile 34
LT - Lituania 34
MA - Marocco 32
RO - Romania 28
MY - Malesia 26
CH - Svizzera 24
CZ - Repubblica Ceca 24
TW - Taiwan 23
UZ - Uzbekistan 23
KE - Kenya 22
VE - Venezuela 22
EG - Egitto 21
TH - Thailandia 21
JM - Giamaica 19
PY - Paraguay 19
TN - Tunisia 19
NP - Nepal 18
AZ - Azerbaigian 17
JO - Giordania 17
SA - Arabia Saudita 16
IL - Israele 15
PT - Portogallo 15
AT - Austria 14
CR - Costa Rica 14
NZ - Nuova Zelanda 14
PA - Panama 14
DZ - Algeria 13
PE - Perù 13
GR - Grecia 12
EU - Europa 10
KZ - Kazakistan 10
RS - Serbia 10
DK - Danimarca 9
TT - Trinidad e Tobago 9
GT - Guatemala 8
HU - Ungheria 8
SV - El Salvador 8
UY - Uruguay 8
AL - Albania 7
DO - Repubblica Dominicana 7
LK - Sri Lanka 7
PS - Palestinian Territory 7
BY - Bielorussia 6
EE - Estonia 6
LB - Libano 6
LV - Lettonia 6
MD - Moldavia 6
BO - Bolivia 5
ET - Etiopia 5
GE - Georgia 5
KG - Kirghizistan 5
PR - Porto Rico 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
HN - Honduras 4
HR - Croazia 4
KW - Kuwait 4
MN - Mongolia 4
NG - Nigeria 4
SC - Seychelles 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
Totale 37.605
Salva come PNG Salva come JPEG
Città #
Southend 1.754
Singapore 1.740
Santa Clara 1.735
Ashburn 1.668
Fairfield 1.243
Chandler 1.067
Hong Kong 1.036
Woodbridge 944
Hefei 798
San Jose 737
Jacksonville 711
Houston 692
Council Bluffs 576
Dearborn 572
Nyköping 523
Ann Arbor 521
Wilmington 507
Beijing 493
Seattle 469
Cambridge 430
London 370
Los Angeles 361
Chicago 340
Ho Chi Minh City 339
Modena 282
Hanoi 271
Seoul 269
The Dalles 248
Helsinki 225
New York 203
Milan 201
Izmir 152
Princeton 149
Sofia 141
Lauterbourg 127
Eugene 126
Salt Lake City 122
San Diego 120
Buffalo 116
Moscow 109
Dallas 106
Columbus 105
Bremen 94
Shanghai 86
São Paulo 81
Rome 80
Redwood City 73
Frankfurt am Main 70
Tampa 64
Da Nang 61
Fremont 61
Tokyo 61
Munich 59
Orem 59
Brussels 55
Des Moines 51
Bologna 50
Elk Grove Village 46
Jakarta 45
Warsaw 43
Atlanta 42
Ottawa 36
Washington 36
Boardman 35
Guangzhou 35
Dublin 34
Mexico City 34
Naples 34
Phoenix 34
Toronto 34
Montreal 33
Rio de Janeiro 33
Haiphong 32
Mumbai 32
San Francisco 32
Chennai 31
Denver 31
Falls Church 31
Johannesburg 31
Lancaster 31
Amsterdam 30
Nanjing 29
Belo Horizonte 27
Brooklyn 26
Kent 25
Miami 25
Miano 25
New Delhi 25
Baghdad 24
Formigine 24
Parma 23
Porto Alegre 23
Dhaka 22
Kunming 22
San Mateo 22
Detroit 21
Charlotte 20
Napoli 20
Tashkent 20
Basingstoke 19
Totale 24.980
Salva come PNG Salva come JPEG
Nome #
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 474
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 463
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 438
The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant 419
Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones? 405
Enhanced anti-hyperproliferative activity of human thymidylate synthase inhibitor peptide by solid lipid nanoparticle delivery 404
Characterization of natural clays from italian deposits with focus on elemental composition and exchange estimated by edx analysis: potential pharmaceutical and cosmetic uses 388
Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis 384
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 383
pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells 380
Gastroretentive montmorillonite-tetracycline nanoclay for the treatment of Helicobacter pylori infection 379
Bead coating process via an excess of crosslinking agent 366
Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy 362
Organo-modified bentonite for gentamicin topical application: interlayer structure and in vivo skin permeation 362
Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid 361
Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector 357
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 356
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 353
Chitosan-alginate microparticles as a protein carrier 348
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug 345
Application of the "in-oil nanoprecipitation" method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 344
Anti-TB inhalation therapy: Design of mannose-based functionalised Solid Lipid Microparticles for an active targeting to alveolar macrophages 343
Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes 338
Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: Characterization and ability to bind the pEGFP-plasmid 336
pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles 336
In vivo penetration of bare and lipid-coated silica nanoparticles across the human stratum corneum 333
In vivo silica nanoparticle translocation across human stratum corneum: the effect of surface hydrophobization in relation to hair follicle density. 332
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 322
Structural investigation and intracellular trafficking of a novel multicomposite cationic solid lipid nanoparticle platform as a pDNA carrier 320
Novel engineered lipid-based nanoparticles for pulmonary tuberculosis inhalation therapy 320
Polymeric and Solid Lipid Nanoparticles for nose-to-brain delivery of geraniolursodeoxycholic acid conjugate: development and characterization studies 318
In vivo detection of lipid-based nano- and microparticles in the outermost human stratum corneum by EDX analysis 314
DEVELOPMENT AND COMPARISON OF TWO LIPID-BASED NANOSYSTEMS FOR THE CO-DELIVERY OF RIFAMPICIN AND ISONIAZID: SMALL-ANGLE NEUTRON SCATTERING CHARACTERISATION 311
Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment-A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability 309
The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier 307
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 304
Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheres 302
Brain uptake of a zidovudine prodrug after nasal administration of solid lipid microparticles 300
In vitro behaviour of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin 298
PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system. 297
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 293
Influence of secondary preparative parameters and aging effects on PLGA particle size distribution: a sedimentation field flow fractionation investigation 292
Vettori particellari per il rilascio sito-specifico di farmaci nel tratto gastro-intestinale 289
Design, Characterization, and In Vitro Assays on Muscle Cells of Endocannabinoid-like Molecule Loaded Lipid Nanoparticles for a Therapeutic Anti-Inflammatory Approach to Sarcopenia 288
Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: Involvement of the drug in the cross-linking process 286
Protein immobilization in crosslinked alginate microparticles 285
pH sensitive PEGylated Liposomes delivering active hydrophilic peptide with anticancer activity: in vitro study on cDDP-resistant ovarian cell line 284
In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form 283
Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method 280
Small-angle neutron scattering characterization of liposomes for anti-tuberculosis inhaled therapy. 279
Cell internalization study of hybrid chitosan-heparin-PLGA nanocarriers on Caco-2 cells 278
In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment? 277
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 275
A hydroxypropylcellulose (HPC) system for the immediate and controlled release of diclofenac sodium 275
Nanoencapsulation of an hTS inhibitor octapeptide against ovarian cancer in solid lipid matrix 274
Self-assembled organogelators as artificial stratum corneum models: key-role parameters for skin permeation prediction 267
SOLID LIPID MICROPARTICLES FOR INHALED ANTI-TB THERAPY BY DPI: INFLUENCE OF THE PRODUCTION PROCESS ON DRUG STABILITY AND POWDER BREATHABILITY 266
Lipid-based microparticles for TB inhaled therapy: physical properties and cell internalization 264
Drug delivery strategies of Geraniol via nose-to-brain for the treatment of neuronal disorders 262
Particulate adducts based on sodium risedronate and titanium dioxide for the bioavailability enhancement of oral administered bisphosphonates 261
Formulazione per veicolare principi attivi lipofili 259
SURFACE ENGINEERING OF SOLID LIPID NANOASSEMBLIES FOR INHALED INTRAMACROPHAGIC ANTI-TB THERAPY 258
Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation 258
Oral tolerance elicited in mice by b-lactoglobulin entrapped in biodegradable microspheres. 257
Development and in vitro characterization of SLN encapsulating magnetic Heparin coated Iron Oxide for theranostic application 256
Dynamic dialysis for the drug release evaluation from doxorubicin-gelatin nanoparticle conjugates 254
PLA-microparticles formulated by means a thermoreversible gel able to modify protein encapsulation and release without being co-encapsulated 253
Caratterizzazione chimico-fisica di membrane e feltri di collagene 251
Inhaled SLM for anti-TB therapy by DPI device: process parameters affecting freeze-drying and breathability 248
Preparation and characterization of biodegradable nanoparticles containing a lipophilic drug in water-soluble or insoluble form 247
Self-assembling organogelators for artificial stratum corneum models: key-role parameters in skin permeation prediction 247
Cationic solid lipid nanoparticles containing Protamine as transfection vector on neuroblastoma cell line 246
Formulazione e caratterizzazione di nanoparticelle polimeriche per la somministrazione orale di eparina 246
In vitro evaluation on CaCo-2 cells of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin. 245
Development of lipid nanocarriers as delivery systems for a small peptide with anti-ovarian activity 242
Studio reologico del complesso alginato/chitosano/albumina per la preparazione di microsfere 240
Intact collagen and atelocollagen sponges: Characterization and ESEM observation 240
Modified PLGA Nanoparticles as drug carriers for CNS delivery 239
Surface drug removal from ibuprofen-loaded PLA microspheres 237
Chitosan/heparin polyelectrolyte complexes as ion-paring approach to encapsulate heparin in orally administrable SLN: In vitro evaluation 234
Metodo per modulare l'assorbimento fagocitario di un principio attivo o un suo precursore da parte di macrofagi 232
A polysorbate-based non-ionic surfactant can modulate loading and release of beta-lactoglobulin entrapped in multiphase poly(DL-lactide-co-glycolide) microspheres 231
Tetracycline-Montmorillonite nanoclay for the treatment of H. pylori infection 231
Inhalated drug delivery systems to target alveolar macrophages for tuberculosis therapy: design of safe SLM loaded with rifampicin 230
In vivo fate and immune pulmonary response after nasal administration of microspheres loaded with phosphorylcholine-thyroglobulin 229
Veicolazione intracellualre di DNA plasmidico mediante solid lipid nanoparticles (SLN) cationiche 228
Polymeric nanoparticles as drug controlled release systems: A new formulation strategy for drugs with small or large molecular weight 227
In vitro evaluation of a potential colonic delivery system that releases drug after a controllable lag-time 227
Caratterizzazione chimico-fisica e studi di stabilità di sistemi lipidici per il transfer genico 227
PROGETTAZIONE E OTTIMIZZAZIONE DI SISTEMI MICROPARTICELLARI PER LA VEICOLAZIONE AI MACROFAGI ALVEOLARI DI FARMACI ANTITUBERCOLARI PER VIA INALATORIA 226
Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease 221
In vitro behaviour of multicomposite cationic SLN as new platform for pDNA delivery 220
Studio della fotodegradazione di un complesso PABA/alginato per la formulazione di filtri solari 219
Sistemi lipidici per il transfer genico: sintesi di nuove molecole per la progettazione di vettori sintetici efficaci 217
The influence of 2-hydroxypropyl-beta-cyclodextrin on the haemolysis induced by bile acids 215
Development of new formulations of cationic solid lipid nanoparticles (SLNs) for the drug delivery to the brain 215
Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy 215
Formulazione per veicolare principi attivi lipofili 214
Ovuli vaginali a rilascio prolungato come inquinanti in pap-test 206
Drug release from perforated matrices containing hydroxypropylcellulose 206
Totale 29.062
Salva come PNG Salva come JPEG
Categoria #
all - tutte 137.402
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.402
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.218 0 0 233 158 86 174 125 134 314 196 510 288
2022/20232.985 464 350 212 326 337 419 56 243 332 48 113 85
2023/20241.624 77 117 129 161 340 176 161 160 46 38 78 141
2024/20256.582 272 71 187 432 1.203 796 543 499 670 243 748 918
2025/202612.085 780 504 949 1.330 1.828 809 1.491 676 1.297 1.218 655 548
2026/20271.394 363 974 57 0 0 0 0 0 0 0 0 0
Totale 37.971